Herpes Zoster following Recombinant COVID-19 Vaccine: A Case Series
Shreya Poddara b c, Indrashis Poddera b c d✉
- aDepartment of Dermatology, Asansol District Hospital, Asansol, West Bengal, India
- b1Department of Dermatology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India
- cThis is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
- dDepartment of Dermatology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
The ongoing novel coronavirus pandemic caused by the SARS-COV-2 virus has severely affected the global population. As various vaccines are being introduced to combat this virus, several adverse effects are being commonly reported such as mucocutaneous reactions, local injection site reactions, and delayed hypersensitivity reactions manifesting as “COVID arm.” However, uncommon side effects like reactivation of certain viruses are also being recently reported. We are reporting three cases of herpes zoster which occurred following the first dose of the recombinant COVID-19 AZD1222 vaccine, to generate awareness about this uncommon sequel.
TL;DRThis work is reporting three cases of herpes zoster which occurred following the first dose of the recombinant COVID-19 AZD1222 vaccine, to generate awareness about this uncommon sequel. (Semantic Scholar)